Drugs give FTSE a lift

clock

The FTSE 100 index has lost 28.6 points, or 0.5%, to 5,856 points this morning, led by AstraZeneca.

Drug giant AstraZeneca has slipped back 1.04% to £32.30 after ING Financial changed its “buy” recommendation to “hold” as it awaits key developments over the next few months. William Morrison has fallen 0.62% to 200.5p after HSBC rated it as "overweight" with a price target of 240p. Sainsbury has been started with an 'underweight' recommendation and has fallen 0.22% to 334.25p. In Japan, the Nikkei 225 Stock Average added 66.88 points, or 0.4%, to 15,638.5 points as a US manufacturing report fuelled speculation the Federal Reserve might refrain from raising interest rates. Sony ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

What advisers need to know as SpaceX fuels space investing interest

What advisers need to know as SpaceX fuels space investing interest

WisdomTree’s Mobeen Tahir unpacks the space economy theme

Sophia Panayi
clock 14 August 2026 • 1 min read
How markets have developed in 2026 so far

How markets have developed in 2026 so far

'Active allocation does not mean constant trading or short-term market calls'

James Flintoft
clock 12 August 2026 • 3 min read
How sustainable funds have beaten the index this year

How sustainable funds have beaten the index this year

'ESG funds benefit from access to some of the livelier parts of the market'

Ian Aylward
clock 10 August 2026 • 3 min read